The latest quarterly R&D expense is $231.28 Million with a QoQ Growth of +11.59%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Reported quarterly R&D expense; no daily interpolation. Q2 FY2026 (2026-06-30): $231.28M.
$231.28M
$231.28 Million
+11.59%
vs. $207.25M prior quarter
23
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | $231.28M | +11.59% | +17.63% |
| Q1 FY2026Period end 2026-03-31 | $207.25M | +4.20% | +8.35% |
| Q4 FY2025Period end 2025-12-31 | $198.88M | +1.28% | +5.43% |
| Q3 FY2025Period end 2025-09-30 | $196.38M | -0.12% | +17.80% |
| Q2 FY2025Period end 2025-06-30 | $196.61M | +2.79% | +37.70% |
| Q1 FY2025Period end 2025-03-31 | $191.27M | +1.39% | -56.23% |
| Q4 FY2024Period end 2024-12-31 | $188.64M | +13.16% | +69.08% |
| Q3 FY2024Period end 2024-09-30 | $166.70M | +16.76% | +53.95% |
| Q2 FY2024Period end 2024-06-30 | $142.78M | -67.33% | +30.12% |
| Q1 FY2024Period end 2024-03-31 | $437.03M | +291.72% | +301.80% |
| Q4 FY2023Period end 2023-12-31 | $111.57M | +3.03% | +5.03% |
| Q3 FY2023Period end 2023-09-30 | $108.28M | -1.31% | +13.82% |
| Q2 FY2023Period end 2023-06-30 | $109.73M | +0.88% | +26.66% |
| Q1 FY2023Period end 2023-03-31 | $108.77M | +2.39% | +40.93% |
| Q4 FY2022Period end 2022-12-31 | $106.22M | +11.66% | +55.15% |
| Q3 FY2022Period end 2022-09-30 | $95.13M | +9.82% | +73.86% |
| Q2 FY2022Period end 2022-06-30 | $86.63M | +12.24% | -2.87% |
| Q1 FY2022Period end 2022-03-31 | $77.18M | +12.73% | +73.04% |
| Q4 FY2021Period end 2021-12-31 | $68.47M | +25.12% | +109.80% |
| Q3 FY2021Period end 2021-09-30 | $54.72M | -38.65% | N/A |
| Q2 FY2021Period end 2021-06-30 | $89.19M | +99.98% | N/A |
| Q1 FY2021Period end 2021-03-31 | $44.60M | +36.67% | N/A |
| Q4 FY2020Period end 2020-12-31 | $32.63M | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
